Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

76 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Delivering integrated strategies from a mobile unit to address the intertwining epidemics of HIV and addiction in people who inject drugs: the HPTN 094 randomized controlled trial protocol (the INTEGRA Study).
Goodman-Meza D, Shoptaw S, Hanscom B, Smith LR, Andrew P, Kuo I, Lake JE, Metzger D, Morrison EAB, Cummings M, Fogel JM, Richardson P, Harris J, Heitner J, Stansfield S, El-Bassel N; HPTN 094 Study Team. Goodman-Meza D, et al. Among authors: stansfield s. Trials. 2024 Feb 15;25(1):124. doi: 10.1186/s13063-023-07899-5. Trials. 2024. PMID: 38360750 Free PMC article.
Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication.
Goodwin GM, Croal M, Feifel D, Kelly JR, Marwood L, Mistry S, O'Keane V, Peck SK, Simmons H, Sisa C, Stansfield SC, Tsai J, Williams S, Malievskaia E. Goodwin GM, et al. Among authors: stansfield sc. Neuropsychopharmacology. 2023 Sep;48(10):1492-1499. doi: 10.1038/s41386-023-01648-7. Epub 2023 Jul 13. Neuropsychopharmacology. 2023. PMID: 37443386 Free PMC article. Clinical Trial.
Population-level impact of expanding PrEP coverage by offering long-acting injectable PrEP to MSM in three high-resource settings: a model comparison analysis.
Stansfield SE, Heitner J, Mitchell KM, Doyle CM, Milwid RM, Moore M, Donnell DJ, Hanscom B, Xia Y, Maheu-Giroux M, Vijver DV, Wang H, Barnabas R, Boily MC, Dimitrov DT. Stansfield SE, et al. J Int AIDS Soc. 2023 Jul;26 Suppl 2(Suppl 2):e26109. doi: 10.1002/jia2.26109. J Int AIDS Soc. 2023. PMID: 37439080 Free PMC article.
Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of life.
Goodwin GM, Aaronson ST, Alvarez O, Atli M, Bennett JC, Croal M, DeBattista C, Dunlop BW, Feifel D, Hellerstein DJ, Husain MI, Kelly JR, Lennard-Jones MR, Licht RW, Marwood L, Mistry S, Páleníček T, Redjep O, Repantis D, Schoevers RA, Septimus B, Simmons HJ, Soares JC, Somers M, Stansfield SC, Stuart JR, Tadley HH, Thiara NK, Tsai J, Wahba M, Williams S, Winzer RI, Young AH, Young MB, Zisook S, Malievskaia E. Goodwin GM, et al. Among authors: stansfield sc. J Affect Disord. 2023 Apr 14;327:120-127. doi: 10.1016/j.jad.2023.01.108. Epub 2023 Feb 4. J Affect Disord. 2023. PMID: 36740140 Free article. Clinical Trial.
Predicted effects of the introduction of long-acting injectable cabotegravir pre-exposure prophylaxis in sub-Saharan Africa: a modelling study.
Smith J, Bansi-Matharu L, Cambiano V, Dimitrov D, Bershteyn A, van de Vijver D, Kripke K, Revill P, Boily MC, Meyer-Rath G, Taramusi I, Lundgren JD, van Oosterhout JJ, Kuritzkes D, Schaefer R, Siedner MJ, Schapiro J, Delany-Moretlwe S, Landovitz RJ, Flexner C, Jordan M, Venter F, Radebe M, Ripin D, Jenkins S, Resar D, Amole C, Shahmanesh M, Gupta RK, Raizes E, Johnson C, Inzaule S, Shafer R, Warren M, Stansfield S, Paredes R, Phillips AN; HIV Modelling Consortium. Smith J, et al. Among authors: stansfield s. Lancet HIV. 2023 Apr;10(4):e254-e265. doi: 10.1016/S2352-3018(22)00365-4. Epub 2023 Jan 12. Lancet HIV. 2023. PMID: 36642087 Free PMC article.
76 results